Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
According to the latest research, the global Veterinary Follicle Stimulating Hormones (FSH) market size was valued at USD 42.62 million in 2022 and is expected to expand at a CAGR of 5.23% during the forecast period, reaching USD 57.87 million by 2028.
Follicle-stimulating hormone is a hormone secreted by basophils in the anterior pituitary gland. Its component is glycoprotein, and its main function is to promote the maturation of follicles. Follicle stimulating hormone can promote the proliferation and differentiation of granulosa cells in the follicle, and promote the growth of the entire ovary. Follicle Stimulating Hormone (FSH) is an important part of the reproductive system. It is responsible for the growth of follicles. This report studies veterinary follicle stimulating hormone, not human FSH.
People's demand for protein is rising
With the continuous improvement of people's living standards, dietary concepts are also constantly updated, and daily eating habits have shifted to high-protein, low-fat animal food. Take the United States as an example. In the past ten years, the per capita consumption of lamb in the United States has been stable at about 1 pound per person per year, and nearly 20% of the consumption of lamb occurred during the spring break. Urban shoppers are most likely to consume lamb, with the highest consumption on the east and west coasts. The American Lamb Board (ALB) has approved a new long-term plan for 2018-2022. The strategic goal of the plan is to increase the demand for American lamb by 2% each year over the next five years, and the total demand will increase by 10%. Lamb is characterized by more lean meat, less fat content, fresh meat quality, rich nutrition, easy digestion, and relatively low cholesterol content, so it is favored by consumers. The increasing demand for protein will promote the development of the aquaculture industry, thereby promoting the development of follicle stimulating hormone for animals.
Veterinary follicle stimulating hormone extraction technology requires high
At present, the hormones available on the market are almost entirely obtained from the pituitary gland extracts of pigs slaughtered in slaughterhouses, and there is less FSH in the pituitary gland. Although veterinary follicle stimulating hormone is widely used in cattle and sheep and other breeding industries, there are some factors that affect the quality of extracting follicle stimulating hormone from the pituitary gland. For example, the product has a high risk of contamination by pathogens and is easily affected by other hormones. Other hormones will interfere with the assisted fertilization process to varying degrees, and will also cause significant differences in the active ingredients between each production batch. To a certain extent, this requires manufacturers to continuously improve their own technical requirements to ensure product quality.
The market is relatively concentrated
At present, there are relatively few manufacturers in the market that can invest in Veterinary Follicle Stimulating Hormones (FSH) synthesis. This also means that most of the profits in the market are concentrated in the hands of a few players. On the one hand, this raises the barriers to entry for the industry to a certain extent, including technology and capital barriers. On the other hand, the existence of collusion and coordination behaviors among a few companies and the behavior of restricting competition through market entry barriers have weakened the competitiveness of the market.
Region Overview:
In global comparison, a significant portion of the revenue was generated in Europe (25.76% in 2022).
Company Overview:
Vetoquinol is one of the major players operating in the Veterinary Follicle Stimulating Hormones (FSH) market, holding a share of 61.2% in 2023.
Vetoquinol
Vetoquinol ranks among the top 10 veterinary drug laboratories in the world, first as an independent family business. Firmly committed to its values, it has always maintained a close relationship with its veterinary customers.
ICPbio
ICPbio Reproduction produces a full range of embryo-friendly media for the embryo transfer market. ICPbio Reproduction conducts all production activities in a GMP (Good Manufacturing Practice) facility.
Segmentation Overview:
As for product types, the Pig segment held the largest market share in 2022.
Application Overview:
The market's largest segment by application is the segment Bovine, with a market share of 60.36% in 2022.
This report elaborates on the market size, market characteristics, and market growth of the Veterinary Follicle Stimulating Hormones (FSH) industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Veterinary Follicle Stimulating Hormones (FSH). The report also introduces players in the industry from the perspective of the value chain and looks into the leading companies.
Key Points this Global Veterinary Follicle Stimulating Hormones (FSH) Market Report Include:
Market Size Estimates: Veterinary Follicle Stimulating Hormones (FSH) market size estimation in terms of revenue and sales from 2018-2028
Market Dynamic and Trends: Veterinary Follicle Stimulating Hormones (FSH) market drivers, restraints, opportunities, and challenges
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Veterinary Follicle Stimulating Hormones (FSH) market
Segment Market Analysis: Veterinary Follicle Stimulating Hormones (FSH) market revenue and sales by type and by application from 2018-2028
Regional Market Analysis: Veterinary Follicle Stimulating Hormones (FSH) market situations and prospects in major and top regions and countries
Veterinary Follicle Stimulating Hormones (FSH) Market
Veterinary Follicle Stimulating Hormones (FSH) Industry Chain: Veterinary Follicle Stimulating Hormones (FSH) market raw materials & suppliers, manufacturing process, distributors by region, downstream customers
Veterinary Follicle Stimulating Hormones (FSH) Industry News, Policies by regions
Veterinary Follicle Stimulating Hormones (FSH) Industry Porters Five Forces Analysis
Key players in the global Veterinary Follicle Stimulating Hormones (FSH) market are covered in Chapter 2:
Ningbo Second Hormone
Vetoquinol
Calier
ICPbio
Reprobiol
In Chapter 6 and Chapter 9, on the basis of types, the Veterinary Follicle Stimulating Hormones (FSH) market from 2018 to 2028 is primarily split into:
Pig
Others
In Chapter 7 and Chapter 10, on the basis of applications, the Veterinary Follicle Stimulating Hormones (FSH) market from 2018 to 2028 covers:
Bovine
Sheep
Horse
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions from 2018 to 2028 are covered in Chapter 8 and Chapter 11:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
In summary, this report relies on sources from both primary and secondary, combines comprehensive quantitative analysis with detailed qualitative analysis, and pictures the market from a macro overview to micro granular segment aspects. Whatever your role in this industry value chain is, you should benefit from this report with no doubt.
Chapter Outline
This report consists of 12 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 first introduces the product overview, market scope, product classification, application, and regional division, and then summarizes the global Veterinary Follicle Stimulating Hormones (FSH) market size in terms of revenue, sales volume, and average price.
Chapter 2 analyzes the main companies in the Veterinary Follicle Stimulating Hormones (FSH) industry, including their main businesses, products/services, sales, prices, revenue, gross profit margin, and the latest developments/updates.
Chapter 3 is an analysis of the competitive environment of Veterinary Follicle Stimulating Hormones (FSH) market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the market concentration ratio in 2022 and the players' M&A and expansion in recent years.
Chapter 4 is an analysis of the Veterinary Follicle Stimulating Hormones (FSH) industrial chain, including raw material analysis, manufacturing cost structure, distributors, and major downstream buyers.
Chapter 5 focuses on Veterinary Follicle Stimulating Hormones (FSH) market dynamics and marketing strategy analysis, which include opportunities, challenges, industry development trends under inflation, industry news and policies analyzed by region, Porter's Five Forces analysis, as well as direct and indirect marketing, and the development trends of marketing channels.
Chapters 6-8 have segmented the Veterinary Follicle Stimulating Hormones (FSH) market by type, application, and region, with a focus on sales and value from 2018 to 2023 from both vertical and horizontal perspectives.
Chapters 9-11 provide detailed Veterinary Follicle Stimulating Hormones (FSH) market forecast data for 2023-2028, broken down by type and application, region, and major countries to help understand future growth trends.
Chapter 12 concludes with an explanation of the data sources and research methods. Verify and analyze through preliminary research to obtain final quantitative and qualitative data.
2022
Follicle-stimulating hormone is a hormone secreted by basophils in the anterior pituitary gland. Its component is glycoprotein, and its main function is to promote the maturation of follicles. Follicle stimulating hormone can promote the proliferation and differentiation of granulosa cells in the follicle, and promote the growth of the entire ovary. Follicle Stimulating Hormone (FSH) is an important part of the reproductive system. It is responsible for the growth of follicles. This report studies veterinary follicle stimulating hormone, not human FSH.
People's demand for protein is rising
With the continuous improvement of people's living standards, dietary concepts are also constantly updated, and daily eating habits have shifted to high-protein, low-fat animal food. Take the United States as an example. In the past ten years, the per capita consumption of lamb in the United States has been stable at about 1 pound per person per year, and nearly 20% of the consumption of lamb occurred during the spring break. Urban shoppers are most likely to consume lamb, with the highest consumption on the east and west coasts. The American Lamb Board (ALB) has approved a new long-term plan for 2018-2022. The strategic goal of the plan is to increase the demand for American lamb by 2% each year over the next five years, and the total demand will increase by 10%. Lamb is characterized by more lean meat, less fat content, fresh meat quality, rich nutrition, easy digestion, and relatively low cholesterol content, so it is favored by consumers. The increasing demand for protein will promote the development of the aquaculture industry, thereby promoting the development of follicle stimulating hormone for animals.
Veterinary follicle stimulating hormone extraction technology requires high
At present, the hormones available on the market are almost entirely obtained from the pituitary gland extracts of pigs slaughtered in slaughterhouses, and there is less FSH in the pituitary gland. Although veterinary follicle stimulating hormone is widely used in cattle and sheep and other breeding industries, there are some factors that affect the quality of extracting follicle stimulating hormone from the pituitary gland. For example, the product has a high risk of contamination by pathogens and is easily affected by other hormones. Other hormones will interfere with the assisted fertilization process to varying degrees, and will also cause significant differences in the active ingredients between each production batch. To a certain extent, this requires manufacturers to continuously improve their own technical requirements to ensure product quality.
The market is relatively concentrated
At present, there are relatively few manufacturers in the market that can invest in Veterinary Follicle Stimulating Hormones (FSH) synthesis. This also means that most of the profits in the market are concentrated in the hands of a few players. On the one hand, this raises the barriers to entry for the industry to a certain extent, including technology and capital barriers. On the other hand, the existence of collusion and coordination behaviors among a few companies and the behavior of restricting competition through market entry barriers have weakened the competitiveness of the market.
Region Overview:
In global comparison, a significant portion of the revenue was generated in Europe (25.76% in 2022).
Company Overview:
Vetoquinol is one of the major players operating in the Veterinary Follicle Stimulating Hormones (FSH) market, holding a share of 61.2% in 2023.
Vetoquinol
Vetoquinol ranks among the top 10 veterinary drug laboratories in the world, first as an independent family business. Firmly committed to its values, it has always maintained a close relationship with its veterinary customers.
ICPbio
ICPbio Reproduction produces a full range of embryo-friendly media for the embryo transfer market. ICPbio Reproduction conducts all production activities in a GMP (Good Manufacturing Practice) facility.
Segmentation Overview:
As for product types, the Pig segment held the largest market share in 2022.
Application Overview:
The market's largest segment by application is the segment Bovine, with a market share of 60.36% in 2022.
This report elaborates on the market size, market characteristics, and market growth of the Veterinary Follicle Stimulating Hormones (FSH) industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Veterinary Follicle Stimulating Hormones (FSH). The report also introduces players in the industry from the perspective of the value chain and looks into the leading companies.
Key Points this Global Veterinary Follicle Stimulating Hormones (FSH) Market Report Include:
Market Size Estimates: Veterinary Follicle Stimulating Hormones (FSH) market size estimation in terms of revenue and sales from 2018-2028
Market Dynamic and Trends: Veterinary Follicle Stimulating Hormones (FSH) market drivers, restraints, opportunities, and challenges
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Veterinary Follicle Stimulating Hormones (FSH) market
Segment Market Analysis: Veterinary Follicle Stimulating Hormones (FSH) market revenue and sales by type and by application from 2018-2028
Regional Market Analysis: Veterinary Follicle Stimulating Hormones (FSH) market situations and prospects in major and top regions and countries
Veterinary Follicle Stimulating Hormones (FSH) Market
Competitive Landscape
and Major Players: Analysis of 10-15 leading market players, sales, price, revenue, gross, gross margin, product/service profile and recent development/updates, etc.Veterinary Follicle Stimulating Hormones (FSH) Industry Chain: Veterinary Follicle Stimulating Hormones (FSH) market raw materials & suppliers, manufacturing process, distributors by region, downstream customers
Veterinary Follicle Stimulating Hormones (FSH) Industry News, Policies by regions
Veterinary Follicle Stimulating Hormones (FSH) Industry Porters Five Forces Analysis
Key players in the global Veterinary Follicle Stimulating Hormones (FSH) market are covered in Chapter 2:
Ningbo Second Hormone
Vetoquinol
Calier
ICPbio
Reprobiol
In Chapter 6 and Chapter 9, on the basis of types, the Veterinary Follicle Stimulating Hormones (FSH) market from 2018 to 2028 is primarily split into:
Pig
Others
In Chapter 7 and Chapter 10, on the basis of applications, the Veterinary Follicle Stimulating Hormones (FSH) market from 2018 to 2028 covers:
Bovine
Sheep
Horse
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions from 2018 to 2028 are covered in Chapter 8 and Chapter 11:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
In summary, this report relies on sources from both primary and secondary, combines comprehensive quantitative analysis with detailed qualitative analysis, and pictures the market from a macro overview to micro granular segment aspects. Whatever your role in this industry value chain is, you should benefit from this report with no doubt.
Chapter Outline
This report consists of 12 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 first introduces the product overview, market scope, product classification, application, and regional division, and then summarizes the global Veterinary Follicle Stimulating Hormones (FSH) market size in terms of revenue, sales volume, and average price.
Chapter 2 analyzes the main companies in the Veterinary Follicle Stimulating Hormones (FSH) industry, including their main businesses, products/services, sales, prices, revenue, gross profit margin, and the latest developments/updates.
Chapter 3 is an analysis of the competitive environment of Veterinary Follicle Stimulating Hormones (FSH) market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the market concentration ratio in 2022 and the players' M&A and expansion in recent years.
Chapter 4 is an analysis of the Veterinary Follicle Stimulating Hormones (FSH) industrial chain, including raw material analysis, manufacturing cost structure, distributors, and major downstream buyers.
Chapter 5 focuses on Veterinary Follicle Stimulating Hormones (FSH) market dynamics and marketing strategy analysis, which include opportunities, challenges, industry development trends under inflation, industry news and policies analyzed by region, Porter's Five Forces analysis, as well as direct and indirect marketing, and the development trends of marketing channels.
Chapters 6-8 have segmented the Veterinary Follicle Stimulating Hormones (FSH) market by type, application, and region, with a focus on sales and value from 2018 to 2023 from both vertical and horizontal perspectives.
Chapters 9-11 provide detailed Veterinary Follicle Stimulating Hormones (FSH) market forecast data for 2023-2028, broken down by type and application, region, and major countries to help understand future growth trends.
Chapter 12 concludes with an explanation of the data sources and research methods. Verify and analyze through preliminary research to obtain final quantitative and qualitative data.
Years considered for this report:
Historical Years:
2018-2022Base Year:
2022Estimated Year:
2023Forecast Period:
2023-2028Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
